Research & KnowledgeEvent: September 8, 2026
Epigenome Technologies published a study by Shi Chen, Xiangqi Meng, and Mong-Hong Lee in Cell Host & Microbe showing that a microbial chromatin remodeler drives gastric cancer progression and immune evasion by reprogramming the host epigenome.
Published
Signal category
Research & Knowledge
Quote
“Epigenetics Update - A microbial chromatin remodeler drives gastric cancer progression and immune evasion by reprogramming the host epigenome”
— Epigenome Technologies team
Company
Epigenome Technologies
Single-cell & Bulk epigenetic services for histones, chromatin remodelers, transcription factors, RNA & DNA methylation
- Industry
- Biotechnology Research
- Location
- San Diego, US
- Company size
- 8 employees
We specialize in single-cell multi-omics technologies to study the epigenome in normal and disease states. Our proprietary technology, Paired-Tag, can simultaneously profile histone modification state and gene expression from up to a million single cells in parallel.
Founded 2020